Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. You look at survival for patients with ...

Experts discuss the importance of transitioning cancer care from academic centers to community practices, ensuring patient ...

So I think this is one unmet need. Second, I think when we talk about CAR T, a lot of times we need to think what are the deal breakers for CAR T? So when a patient comes to my clinic, the first two ...

In closing, the panel of experienced multiple myeloma care partners offers a powerful, unified message of hope and actionable advice.

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Here’s my take on myeloma-related studies that I’m excited about now and in the year ahead, with a focus on smoldering multiple myeloma (SMM), newly diagnosed disease, and first relapse. A key advance ...

The U.S. Food and Drug Administration (FDA) recently approved the use of Darzalex Faspro (daratumumab and hyaluronidase-fihj) ...